Kolexia
Iurisci Ida Oncologie médicale
Iurisci Ida
Oncologie médicale
Gcs 3c Inst Oncologie Hds Nord Siege
Levallois-Perret, France
66 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Fatigue Perte de poids Carcinomes Métastase tumorale Grippe humaine {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Marijon Helene
Marijon Helene
Hôpital Franco-Britannique, Levallois-Perret, France
Perez-Staub Nathalie
Perez-Staub Nathalie
Hôpital Franco-Britannique, Levallois-Perret, France
Gervais Honorine
Gervais Honorine
Hôpital Franco-Britannique, Levallois-Perret, France
Rouchou-Bloch Delphine
Rouchou-Bloch Delphine
Hôpital Franco-Britannique, Levallois-Perret, France

Industries

Voir plus
A+A
44 collaboration(s)
Dernière en 2023
B3TSI
17 collaboration(s)
Dernière en 2023
Ipsen
14 collaboration(s)
Dernière en 2023
Novartis
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Surgical management of Low-Grade Serous Carcinoma of the ovary: Results of a multicenter study from The French National Network dedicated to Ovarian Malignant Rare Tumors (TMRO)
European journal of obstetrics, gynecology, and reproductive biology   01 mars 2019
Impact on treatment adherence, side effects control, patients QoL, and rehospitalization rate through new management of oral chemotherapy.
2018 ASCO Annual Meeting I   01 juin 2018
Clock genes expression in breast cancers (BC) from patients (pts) treated with neoadjuvant chemotherapy (NAC) in a randomized multicenter phase II trial.
2014 ASCO Annual Meeting I   20 mai 2014
The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy.
International journal of cancer   25 novembre 2013
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study.
British journal of cancer   03 mai 2011
Abstract P2-09-26: Circadian Clock Genes in Primary Breast Cancer: Strong Predictors of Pathologic Response on Neoadjuvant Chemotherapy
Thirty-Third Annual CTRC AACR San Antonio Breast Cancer Symposium Dec 8 12, 2010   15 décembre 2010
Relations of circadian clocks genes with endocrine, proliferation, differentiation, and P53 mutation status in human locally invasive primary breast cancer.
2010 ASCO Annual Meeting I   20 mai 2010
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}